These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1594 related items for PubMed ID: 19696412

  • 1. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 2. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.
    Papadopoulos P, Bousette N, Al-Ramli W, You Z, Behm DJ, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Atherosclerosis; 2009 Jun 25; 204(2):395-404. PubMed ID: 19111831
    [Abstract] [Full Text] [Related]

  • 3. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE, Assini JM, Sutherland BG, DiMattia AS, Khami M, Koppes JB, Sawyez CG, Whitman SC, Huff MW.
    Arterioscler Thromb Vasc Biol; 2010 Apr 25; 30(4):742-8. PubMed ID: 20110573
    [Abstract] [Full Text] [Related]

  • 4. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, Tsuda M, Okumura M, Min LJ, Mogi M, Horiuchi M.
    Circulation; 2005 Sep 13; 112(11):1636-43. PubMed ID: 16145000
    [Abstract] [Full Text] [Related]

  • 5. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC, Simari RD, Conover CA.
    Circ Res; 2007 Jun 22; 100(12):1696-702. PubMed ID: 17510462
    [Abstract] [Full Text] [Related]

  • 6. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T, Aragane K, Fujinami K, Kojima K, Ishibashi S, Yamada N, Kusunoki J.
    Br J Pharmacol; 2001 Aug 22; 133(7):1005-12. PubMed ID: 11487509
    [Abstract] [Full Text] [Related]

  • 7. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG, Zhu Y, Coleman T, Semenkovich CF.
    Arterioscler Thromb Vasc Biol; 2007 Dec 22; 27(12):2699-706. PubMed ID: 17951320
    [Abstract] [Full Text] [Related]

  • 8. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W, Wang X, Wong J, Hedrick CC, Wong H, Castellani LW, Lusis AJ.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):223-9. PubMed ID: 15047172
    [Abstract] [Full Text] [Related]

  • 9. Alteration of vascular urotensin II receptor in mice with apolipoprotein E gene knockout.
    Wang ZJ, Shi LB, Xiong ZW, Zhang LF, Meng L, Bu DF, Tang CS, Ding WH.
    Peptides; 2006 Apr 23; 27(4):858-63. PubMed ID: 16325305
    [Abstract] [Full Text] [Related]

  • 10. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K, Nishizawa T, Abe K, Wakabayashi K, Oda T, Inaba T, Amemiya Y.
    J Pharm Pharmacol; 2006 Dec 23; 58(12):1629-38. PubMed ID: 17331327
    [Abstract] [Full Text] [Related]

  • 11. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H, Miyata M, Shirasawa T, Akasaki Y, Hamada N, Nagaki A, Orihara K, Biro S, Tei C.
    Hypertens Res; 2008 Aug 23; 31(8):1631-42. PubMed ID: 18971539
    [Abstract] [Full Text] [Related]

  • 12. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y, Watanabe T, Suguro T, Nagashima M, Kato R, Hongo S, Itabe H, Miyazaki A, Hirano T, Adachi M.
    J Hypertens; 2008 Oct 23; 26(10):1955-65. PubMed ID: 18806619
    [Abstract] [Full Text] [Related]

  • 13. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
    Sun L, Ishida T, Yasuda T, Kojima Y, Honjo T, Yamamoto Y, Yamamoto H, Ishibashi S, Hirata K, Hayashi Y.
    Cardiovasc Res; 2009 May 01; 82(2):371-81. PubMed ID: 19176597
    [Abstract] [Full Text] [Related]

  • 14. Elevated expression of urotensin II and its receptor in diethylnitrosamine-mediated precancerous lesions in rat liver.
    Wang H, Dong K, Xue X, Feng P, Wang X.
    Peptides; 2011 Feb 01; 32(2):382-7. PubMed ID: 21056072
    [Abstract] [Full Text] [Related]

  • 15. Urotensin II differentially regulates macrophage and hepatic cholesterol homeostasis.
    Kiss RS, You Z, Genest J, Behm DJ, Giaid A.
    Peptides; 2011 May 01; 32(5):956-63. PubMed ID: 21376094
    [Abstract] [Full Text] [Related]

  • 16. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B, Freund M, Ravanat C, Magnenat S, Cazenave JP, Gachet C.
    Circulation; 2008 Aug 12; 118(7):754-63. PubMed ID: 18663083
    [Abstract] [Full Text] [Related]

  • 17. Modulation of plasma lipid levels affects benzo[a]pyrene-induced DNA damage in tissues of two hyperlipidemic mouse models.
    Curfs DM, Beckers L, Godschalk RW, Gijbels MJ, van Schooten FJ.
    Environ Mol Mutagen; 2003 Aug 12; 42(4):243-9. PubMed ID: 14673869
    [Abstract] [Full Text] [Related]

  • 18. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
    Liu G, Wang B, Zhang J, Jiang H, Liu F.
    J Ethnopharmacol; 2009 Nov 12; 126(2):350-4. PubMed ID: 19703533
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
    Bietrix F, Lombardo E, van Roomen CP, Ottenhoff R, Vos M, Rensen PC, Verhoeven AJ, Aerts JM, Groen AK.
    Arterioscler Thromb Vasc Biol; 2010 May 12; 30(5):931-7. PubMed ID: 20167657
    [Abstract] [Full Text] [Related]

  • 20. FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice.
    Zhang Y, Wang X, Vales C, Lee FY, Lee H, Lusis AJ, Edwards PA.
    Arterioscler Thromb Vasc Biol; 2006 Oct 12; 26(10):2316-21. PubMed ID: 16825595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.